Live tape
Thermo FisherNeo Ivy Capital Management Buys 3,865 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeatIlluminaNeo Ivy Capital Management Invests $1.83 Million in Illumina, Inc. $ILMN - MarketBeatEndpoints NewsUniQure’s dispute with FDA; Zealand’s obesity readout; China takes on world’s most expensive medicines; and moreWatersRep. Kevin Hern Shares of Waters Corporation (NYSE:WAT) - MarketBeatLonza NewsLonza sells off its capsules division to British firm - SWI swissinfo.chThermo FisherRally Mode: How Thermo Fisher Scientific Inc. stock reacts to Fed rate cuts - July 2025 Final Week & AI Driven Stock Reports - Naître et grandirIlluminaIllumina Regeneron Alliance Targets Multiomics And Raises Valuation Questions - Yahoo Finance UKWatersKevin Hern acquires Waters Corporation stock through Hern Family Revocable Trust - Investing.com South AfricaAgilentAgilent Technologies (A) Announces Retirement of Key Executive - GuruFocusFierceBiotechFDA’s Vinay Prasad to depart agency at the end of April10x Genomics BlogLife Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers - Yahoo Finance UK10x Genomics BlogLife Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers - Yahoo Finance Australia
Archive

A tighter archive for life-science signals.

Search once, then narrow by source or topic.

Latest first Oldest first Clear filters
Active topic #Innovation
All stories 20
Active topic Innovation
Active query --
Lonza News Oct 7, 2025

Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk A/S, Pfizer, and Seagen - ResearchAndMarkets.com - Business Wire

Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk...

#Therapeutic Innovations #Forecast Report #Featuring Lonza #Novo Nordisk
Directory ribbon

Brand directory, kept in view

A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.

Open about page